Pharma Journalist -

Genentech, a member of the Roche Group announced that the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled Phase III clinical trial…
Read More...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet…
Read More...

SMi Group have released an official chair invite letter from Kerrie Brady, Chief Business Officer, Centrexion Therapeutics and Michael Scherz, Founder & CEO, Metys Pharma for Pain…
Read More...

SMi reports: SMi Group interviews James Wabby from Allegan for Pre-Filled Syringes West Coast 2020 The 5th annual Pre-Filled Syringes West Coast conference will reconvene on the 14th…
Read More...

As part of the U.S. Food and Drug Administration's ongoing efforts to address the coronavirus pandemic (COVID-19), the agency issued a new guidance to sponsors and healthcare providers…
Read More...

Tarveda Therapeutics, Inc. and SciClone Pharmaceuticals International Ltd. announced that they have entered into a licensing agreement for PEN-866, the initial clinical program from…
Read More...

Junshi Biosciences announced that it has recently signed a collaboration agreement with the Institute of Microbiology of the Chinese Academy of Sciences (IMCAS) to jointly develop…
Read More...

Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Innovations at Emory (DRIVE), LLC, a not-for-profit biotechnology company wholly owned by Emory University,…
Read More...

Dragonfly Therapeutics, Inc. announced an expansion of its strategic collaboration with Merck, known as MSD outside the United States and Canada to discover, develop and commercialize a…
Read More...

Novartis Pharma K.K. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (onasemnogene abeparvovec) for the treatment of spinal muscular atrophy…
Read More...